Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22416728 | 1.00 | KDM4E (0.48) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| SCHEMBL22790769 | 1.00 | KDM4E (0.48) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| SCHEMBL1037554 | 1.00 | KDM4E (0.48) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| SCHEMBL24728 | 1.00 | — | — | |
| SCHEMBL11573949 | 1.00 | KDM4E (0.48) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| SCHEMBL22316957 | 1.00 | KDM4E (0.48) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| SCHEMBL17041905 | 0.97 | KDM4E (0.46) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| Fluoride SCHEMBL9620604 | 0.97 | KDM4E (0.46) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| Ammonia Solution, Strong SCHEMBL28857856 | 0.97 | KDM4E (0.46) | KDM4EKCNH2ALDH1A1HSD17B10SHBG | |
| Bromide SCHEMBL28155616 | 0.97 | KDM4E (0.46) | KDM4EKCNH2ALDH1A1HSD17B10SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100143322-A1 | USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE | PLT PATENT & LICENCE TRADING LTD., C/O THE B-NET (GB) | 2010-06-10 | — | — | US | claimed |
| EP-4694606-A1 | RADIO WAVE SHIELDING BODY AND ADHESIVE COMPOSITION | Zeon Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024204796-A1 | RADIO WAVE SHIELDING BODY AND ADHESIVE COMPOSITION | 日本ゼオン株式会社 | 2024-10-03 | — | — | WO | disclosed |
| EP-4107198-B1 | POLYISOCYANATE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| US-11912714-B2 | Spiropyrrolidine derived antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| EP-3560975-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES AND ANTIOXIDANTS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-12-06 | — | — | EP | disclosed |
| EP-3724251-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023178378-A1 | MIP INHIBITORS | DMTC Limited (AU) | 2023-09-28 | — | — | WO | disclosed |
| EP-3851472-B1 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-20230151019-A1 | NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2023-05-18 | — | — | US | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001047635-A2 | SUPPORTED CATALYST SYSTEM CONTAINING A METALLOCENE, A LEWIS BASE AND AN ELEMENTALLY ORGANIC COMPOUND OF MAIN GROUP III AND THE USE THEREOF | BASELL POLYPROPYLEN GMBH (DE) | 2001-07-05 | — | — | WO | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |
| EP-0206621-B1 | PROCESS FOR DISPROPORTIONATING SILANES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-11-15 | — | — | EP | disclosed |
| EP-0206621-A1 | Process for disproportionating silanes | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-30 | — | — | EP | disclosed |
| EP-0031284-B1 | COMPOSITION AND METHOD FOR INHIBITING THE FORMATION OF NITROSAMINE IN ORGANIC AMINES BY ADDITION OF 1,4-NAPHTHOQUINONE, 1,4-NAPHTHOHYDROQUINONE OR ALKYL DERIVATIVES THEREOF | UNION CARBIDE CORPORATION (US) | 1984-02-01 | — | — | EP | disclosed |
| US-4273937-A | Organic amine compositions | UNION CARBIDE CORPORATION (US) | 1981-06-16 | — | — | US | disclosed |
| US-4169896-A | CONTROL OF COCCIDIAL DISEASES BY TREATMENT OF ANIMAL EXCRETA WITH SECONDARY AMINES | CIBA-GEIGY CORPORATION (US) | 1979-10-02 | — | — | US | disclosed |
| US-4112231-A | Process for the condensation of epoxides with organic compounds having an active hydrogen | BEROL KEMI AB (SE) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151019-A1 | NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | ACE, ACE2, PKD1 | KDM4E 2622/4885KCNH2 738/4885ALDH1A1 386/4885 |
| US-11912714-B2 | Spiropyrrolidine derived antiviral agents | ACE, ACE2, PKD1 | KDM4E 2624/4885KCNH2 542/4885ALDH1A1 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.